Breaking News: FDA Approves Bemotrizinol, a Game-Changing Sunscreen Ingredient
Meanwhile, the FDA has finally approved bemotrizinol, a sunscreen ingredient that has been used in Europe and Asia for decades. This breakthrough comes after over 20 years of waiting, and it’s expected to revolutionize the sunscreen industry.
What’s so special about bemotrizinol?
However, bemotrizinol has a lot of things going for it. One is that it “plays well with other sunscreen ingredients,” as one dermatologist told Women’s Health. You can make lighter, nicer-feeling sunscreens with it, hence the popularity of the Bioré formulation I tried.
Benefits of Bemotrizinol
Moreover, bemotrizinol is more effective at broad-spectrum protection. With our current sunscreen formulations, all active ingredients protect against UVB rays (the rays that cause sunburn) but only a few can also provide protection against UVA rays (which contribute to wrinkling and aging of skin).
Why it’s taken so long
Consequently, the CARES act, passed in 2020 for pandemic relief, provided a way for over-the-counter drugs to be sold without going through the complete approval process, so long as the FDA was satisfied they were safe and effective. Bemotrizinol met the criteria, thanks in large part to the fact that it’s been used safely since 2000 in Europe, Asia, and Australia.
What’s next?
Therefore, the FDA’s rule on bemotrizinol still needs to be finalized, but it seems likely we’ll see new sunscreens on shelves before the end of 2026. This is a significant development for the skincare industry, and we can’t wait to see the impact it will have.
Source: Link
